ACM의 Rat를 이용한 13주 반복 경구투여 독성시험 및 4주 회복시험
A Thirteen Week Repeated Oral Dose Toxicity Test and A Four Week Recovery Test of ACM(Added Chongmyung-tang) in Sprague-Dawley Rats
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives :To provide information on the safety of ACM, we carried out a 13-week repeated oral dose toxicity and a 4-week recovery test of ACM in Sprague-Dawley rats. Methods :Female and male rats were treated with ACM with oral doses of 800, 2000, and 5000 ㎎/㎏. The ACM was administered for 13 weeks. Mortality, clinical signs, body weight changes, food consumption, ophthalmologic findings, urinalysis, hematological and biochemical parameters, gross findings, organ weights and histological markers were monitored during the study period. Moreover, the rats were monitored for 4 extra weeks to determine recovery time after the study period. Results :We found no mortality and no abnormalities in clinical signs, body weight, food consumption, ophthalmologic findings, urinalysis, hematological and biochemical parameters, gross findings, organ weights and histological markers in any of the rats tested. Conclusions :The no-observed adverse effects level (NOAEL) was considered as over 5000 mg/kg for male and female rats.
Abstract
Objectives :To provide information on the safety of ACM, we carried out a 13-week repeated oral dose toxicity and a 4-week recovery test of ACM in Sprague-Dawley rats. Methods :Female and male rats were treated with ACM with oral doses of 800, 2000, and 5000 ㎎/㎏. The ACM was administered for 13 weeks. Mortality, clinical signs, body weight changes, food consumption, ophthalmologic findings, urinalysis, hematological and biochemical parameters, gross findings, organ weights and histological markers were monitored during the study period. Moreover, the rats were monitored for 4 extra weeks to determine recovery time after the study period. Results :We found no mortality and no abnormalities in clinical signs, body weight, food consumption, ophthalmologic findings, urinalysis, hematological and biochemical parameters, gross findings, organ weights and histological markers in any of the rats tested. Conclusions :The no-observed adverse effects level (NOAEL) was considered as over 5000 mg/kg for male and female rats.
참고문헌 (27)
- The Korean society of oriental neuropsychiatry, "Oriental neuropsychiatry", pp.324~333 (2007), Jipmundang
- Oide T, "Regression stage senile plaques in the natural course of alzheimer's disease", Neuropathology appl neurobiology, 32(5), pp.539~56 (2006)
- Sinha S, "Purification and cloning of amyloid precursor protein beta-secretase from human brain", Nature, 402, pp.537~540 (1999)
- McGrath LT, "Increased oxidative stress in alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde", Q J medicin, 94, pp.485~490 (2001)
- David S, "Treatmentguidelines for alzheimer's disease-redefinding perceptions in primary care", Primary care companion J clinic psychiatry, 9(2), pp.113~121 (2007)
- Cheng, "A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer’ disease", Nature, 408, pp.975~979 (2000)
- Heo J, "Dongeuibogam", pp.98~100 (2005), Dongeuibogam publisher
- Lee SI, "Clinical applications of herbal medicine" (1990), Seongbosa
- Kim YW, "Effect of Chongmyungtang on learning and memory in normal and scopolamine-induced amnestic mice", Journal of Oriental Rehabilitation Medicine, 8(2), pp.464~479 (1998)
- 임정화, "八味合聰明湯 열수추출물, 초미세분말제형이 Alzheimer's Disease 병태 모델에 미치는 영향", 동의신경정신과학회지, 19(2), pp.95~110 (2008), 대한한방신경정신과학회
- 김현주, "加味補陽還五湯과 八味合聰明湯의 microglia 보호, 항산화 및 acetylcholinesterase 억제 효과", 동의신경정신과학회지, 19(2), pp.65~76 (2008), 대한한방신경정신과학회
- 이승희, "귀비총명탕 열수추출물과 초미세분말제형이 Alzheimer's Disease 병태 모델에 미치는 영향", 동의생리병리학회지, 21(4), pp.921~933 (2007), 대한동의병리학회
- 최강욱, "聰明湯과 木槿皮聰明湯 열수추출물, 초미세분말제형이 microglia 및 기억력 감퇴 병태모델에 미치는 영향", 동의생리병리학회지, 20(5), pp.1200~1210 (2006), 대한동의병리학회
- Department of the national association of Herbalogy, "Herbalogy" (2008), Youngrimsa
- Kim HS, "Effects of Morinda officinalis(MDOF) on inhibition of impairment of learning and memory, and acetylcholinesterase in amnesia mice", Journal of oriental neuropsychiatry, 14(1), pp.45~58 (2003)
- Chae JG, "BR(CPVM)extract on the the Alzheimer's disease model induced by CT105", Journal of oriental neuropsychiatry, 13(1), pp.79~115 (2002)
- 하수영, "聰明湯과 山査聰明湯이 Alzheimer's Disease 病態 모델에 미치는 影響", 동의신경정신과학회지, 17(1), pp.59~78 (2006), 대한한방신경정신과학회
- 임정화, "聰明湯과 巴戟天聰明湯 열수추출물, 초미세분말제형이 microglia 및 기억력 감퇴 병태모델에 미치는 영향", 동의생리병리학회지, 20(4), pp.997~1008 (2006), 대한동의병리학회
- 임정화, "In vitro에서 β-site amyloid precursor protein-cleaving enzyme 활성과 amyloid β protein 생산에 대한 聰明湯加味方의 효과", 동의신경정신과학회지, 21(2), pp.191~200 (2010), 대한한방신경정신과학회
- Lee KW, "Clinical neurology", pp.203~215 (2003), Beommunsa
- The mapping development research of dementia management, "Byeon YC", Korea Institute for Health and Social Affairs, ~ (1997)
- Citron M, "Evidence that the 42-and 40-amino acid forms of amyloid beta protein aregenerated from the beta-amyloid precursor protein by different protease activities", Proc. Natl. Acad. Sci, 93 (1996)
- John V, "Human beta-secretase (BACE) and BACE inhibitors", J. Med. Chem, 46(22), pp.4625~4630 (2003)
- Je JY, "Water-soluble chitosan derivatives as a BACE1 inhibitor", Bioorg. Med. Chem. Lett, 13, pp.6551~6655 (2005)
- Cheong MH, "Anti-inflammatory effects of Polygala tenuifolia root through inhibition of NF-kappa B activation in lipopolysaccharide-induced BV2 microglial cells", JOURNAL OF ETHNOPHARMACOLOGY, 137(3), pp.1402~1408 (2011), ELSEVIER IRELAND LTD
- 박은경, "총명탕, 원지, 석창포가 베타아밀로이드로 유발된 학습과 기억장애에 미치는 영향", 대한한방내과학회지, 29(3), pp.608~620 (2008), 대한한방내과학회
- 최우창, "ACM의 Sprague-Dawley Rat 경구 단회 투여 독성시험", 동의신경정신과학회지, 23(2), pp.121~128 (2012), 대한한방신경정신과학회[DOI]